ProGAP: Comparing prostate cancer care around the world
Evaluating the Worldwide Landscape of Prostate Cancer Management
This project will ask prostate cancer doctors worldwide to complete a short online survey to see if patients in low- and middle-income countries get the same diagnostic tests and treatments as those in high-income countries.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Sex | All |
| Sponsor | Ankara University Academic / other |
| Drugs / interventions | Radiation |
| Locations | 1 site (Ankara, Ankara) |
| Trial ID | NCT06612034 on ClinicalTrials.gov |
What this trial studies
ProGAP is an international, cross-sectional survey that collects practice-level data from physicians who treat prostate cancer to map differences in diagnosis and management across countries grouped by income level. Participants complete a 17-question online survey covering demographics, clinical practice environment, patient stages treated, guideline adherence, availability and use of diagnostic and treatment options, and multidisciplinary care. The study compares responses across low-, lower-middle-, upper-middle-, and high-income settings to quantify disparities in access to standard and novel therapies. Results will be analyzed centrally by the coordinating team at Ankara University.
Who should consider this trial
Good fit: Physicians who actively treat prostate cancer—urologists, uro-oncologists, medical oncologists, and radiation oncologists—are eligible to participate.
Not a fit: Patients who receive care from non-participating clinicians or live in countries not represented in the survey may not see immediate benefit.
Why it matters
Potential benefit: If successful, the results could identify care gaps so health systems and policymakers can target resources and guidelines to improve access and outcomes for patients.
How similar studies have performed: Previous international surveys and observational studies have documented regional gaps in cancer care, so the approach is established though comprehensive global comparisons remain limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Urologists, Uro-oncologists, Medical oncologists, Radiation oncologists Exclusion Criteria: Non-clinical healthcare professionals Healthcare professionals not directly involved in the care of prostate cancer patients, Healthcare professionals with missing or incorrect email addresses
Where this trial is running
Ankara, Ankara
- Ankara University Faculty of Medicine — Ankara, Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Yüksel Ürün
- Email: yukselurun@gmail.com
- Phone: 800-555-5555
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.